The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 24.00
Ask: 25.00
Change: -1.00 (-3.92%)
Spread: 1.00 (4.167%)
Open: 25.50
High: 25.50
Low: 24.50
Prev. Close: 25.50
RENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Renalytix Plc

13 Mar 2024 19:24

Pentwater Capital Management LP - Form 8.3 - Renalytix Plc

Pentwater Capital Management LP - Form 8.3 - Renalytix Plc

PR Newswire

LONDON, United Kingdom, March 13

FORM 8.3

AMENDMENT FOR DISCLOSURE

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Pentwater Capital Management LP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeRenalytix plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure12/03/2024
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:0.25p Ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:2,365,009.001.9722%
(2) Cash-settled derivatives:1,049,991.000.8756%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:3,415,000.002.8478%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:0.25p Ordinary
Details, including nature of the rights concerned and relevant percentages:2,589,441.00 shares

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:13/03/2024
Contact name:Hooman Tavakolian
Telephone number:+1 312 914 4301

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.



Date   Source Headline
26th Apr 20245:34 pmRNSHolding(s) in Company
26th Apr 20244:32 pmRNSForm 8.3 - Renalytix PLC
26th Apr 20244:25 pmRNSHolding(s) in Company
26th Apr 202412:09 pmRNSForm 8.3 - Renalytix plc
26th Apr 202412:07 pmRNSForm 8.3 - Renalytix plc
26th Apr 202412:05 pmRNSForm 8.3 -Renalytix plc
26th Apr 202412:05 pmRNSForm 8.3 - Renalytix plc
26th Apr 202412:04 pmRNSForm 8.3 - Renalytix PLC
26th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
26th Apr 202411:39 amPRNForm 8.3 - Renalytix PLC
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
26th Apr 20247:59 amRNSForm 8.3 - Renalytix PLC
25th Apr 20242:22 pmRNSAllotment and issue of Second Tranche Shares
25th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
25th Apr 20246:45 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
24th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
24th Apr 20247:38 amGNWForm 8.5 (EPT/RI) - Renalytix plc
23rd Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
22nd Apr 20245:27 pmRNSIssue of Shares and Rule 2.9 Announcement
22nd Apr 20244:09 pmRNSResult of General Meeting
22nd Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
18th Apr 20241:13 pmRNSForm 8.3 - Renalytix plc
18th Apr 20247:00 amRNSManagement Change
17th Apr 20245:17 pmRNSForm 8.3 - Renalytix plc
17th Apr 20242:57 pmRNSForm 8.3 - Renalytix plc
17th Apr 20242:29 pmRNSForm 8.3 - Renalytix PLC
17th Apr 20242:27 pmRNSForm 8.3 - Renalytix plc
16th Apr 20241:08 pmRNSRule 2.9 Announcement
16th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
15th Apr 20245:58 pmRNSForm 8.3 - Renalytix plc
15th Apr 20244:23 pmRNSHolding(s) in Company
15th Apr 20243:54 pmRNSCompletion of Financing and Total Voting Rights
15th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
15th Apr 20247:46 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
12th Apr 20243:51 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSRule 2.9 Announcement
10th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
10th Apr 202410:00 amRNSIssue of Shares
9th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
9th Apr 20247:24 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
8th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
8th Apr 20247:50 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
8th Apr 20247:44 amRNSFinancing with Expected Size of up to $4 Million
5th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
5th Apr 202411:39 amRNSChange of Registered Address
4th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
4th Apr 20247:31 amGNWForm 8.5 (EPT/RI) - Renalytix plc
3rd Apr 20243:02 pmRNSNotice of GM
3rd Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
3rd Apr 20247:46 amGNWForm 8.5 (EPT/RI) - Renalytix plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.